Taysha Gene Therapies Is Showing Promise For Rett Syndrome
Taysha Gene Therapies(TSHA) Seeking Alpha·2025-01-28 00:53Group 1 - Taysha Gene Therapies is a clinical-stage biotech company focused on developing gene therapies, with its leading candidate being TSHA-102 for Rett syndrome [1] - TSHA-102 utilizes "self-complementary" adeno viruses (scAAV) to deliver its treatment [1]